NutrigeneAI Biotech Limited, in collaboration with the Biotechnology, Entrepreneurship and Healthcare Management (BEHM) Programme at The Chinese University of Hong Kong (CUHK), successfully co-hosted the Symposium on Stem Cell Therapies: Roadmap to Clinical Applications on December 12, 2025, at CUHK.
The symposium convened leading clinicians, academic researchers, and industry professionals to examine translational pathways for stem cell–based therapies. Discussions focused on induced pluripotent stem cell (iPSC) technologies, clinical manufacturing and quality systems, regulatory considerations, and real-world applications in regenerative medicine.
